| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4177505
Max Phase: Preclinical
Molecular Formula: C32H25F4NO3S
Molecular Weight: 579.62
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(COc3cccc4ccccc34)cc2)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C32H25F4NO3S/c33-28-8-3-5-22(17-28)15-16-37-41(38,39)29-19-26(18-27(20-29)32(34,35)36)24-13-11-23(12-14-24)21-40-31-10-4-7-25-6-1-2-9-30(25)31/h1-14,17-20,37H,15-16,21H2
Standard InChI Key: CTJCRQQLSMYSBJ-UHFFFAOYSA-N
Associated Targets(Human)
Receptor protein-tyrosine kinase erbB-4 2748 Activities
3-phosphoinositide dependent protein kinase-1 3758 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Ephrin type-A receptor 3 1582 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 579.62 | Molecular Weight (Monoisotopic): 579.1491 | AlogP: 7.76 | #Rotatable Bonds: 9 |
| Polar Surface Area: 55.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 9.91 | CX Basic pKa: | CX LogP: 8.04 | CX LogD: 8.04 |
| Aromatic Rings: 5 | Heavy Atoms: 41 | QED Weighted: 0.18 | Np Likeness Score: -1.27 |
References
| 1. Giordano A, Forte G, Massimo L, Riccio R, Bifulco G, Di Micco S.. (2018) Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening., 152 [PMID:29730188] [10.1016/j.ejmech.2018.04.018] |
Source
Source(1):